SenesTech, which is commercializing a non-lethal rodent control chemical that lowers rat fertility, filed on Wednesday with the SEC to raise up to $29 million in an initial public offering.
The Flagstaff, AZ-based company was founded in 2004 and plans to list on the Nasdaq under the symbol SNES. SenesTech filed confidentially on August 3, 2016. Roth Capital is the sole bookrunner on the deal. No pricing terms were disclosed.
